Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports-February 2024-www.financetom.com

Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports

Sep 22, 2024 9:35 PM

Sept 23 (Reuters) - Novo Nordisk's chief

executive is preparing for a showdown next week with U.S.

Senator Bernie Sanders over the high price of blockbuster

diabetes and weight loss drugs, as Ozempic falls into the scope

of U.S. government price controls, the Financial Times reported

on Monday.

Previous page： Capital One Financial, Walmart End Consumer Credit Card Partnership Agreement Next page： Workday's Subscription-Revenue Outlook Cut Driven by 2 Factors, Morgan Stanley Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Capital One Financial, Walmart End Consumer Credit Card Partnership Agreement

May 24, 2024

09:30 AM EDT, 05/24/2024 (MT Newswires) -- Capital One Financial ( COF ) and Walmart ( WMT ) said Friday they have ended their card partnership for Capital One to be the exclusive issuer of Walmart ( WMT ) consumer credit cards. There are no immediate changes for cardholders, the companies said in a joint statement. Capital One will retain...

Workday's Subscription-Revenue Outlook Cut Driven by 2 Factors, Morgan Stanley Says

May 24, 2024

09:34 AM EDT, 05/24/2024 (MT Newswires) -- Workday's (WDAY) lower subscription-revenue guidance for fiscal year 2025 was driven relatively evenly by slower customer headcount growth commitments and increased scrutiny of large deals, Morgan Stanley said Friday in a note. While Q1 is a seasonally slow quarter and notoriously volatile, the weaker performance is likely to stoke investor concerns on two...

US safety probe into Waymo self-driving vehicles finds more incidents

May 24, 2024

WASHINGTON (Reuters) -The National Highway Traffic Safety Administration said Friday it has learned of nine additional incidents that raise concerns about the performance of Alphabet's Waymo self-driving vehicles. Earlier this month, the U.S. auto safety regulator opened an investigation after 22 reports of its robotaxis exhibiting driving behavior that potentially violated traffic safety laws, or demonstrating other unexpected behavior, including...

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

May 24, 2024

May 24 (Reuters) - Eli Lilly ( LLY ) said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling its previous investment, as it scrambles to meet soaring demand for its weight-loss and diabetes drugs. The new investment, which brings the total to $9 billion, will help boost production of the...